Literature DB >> 25219340

ET-1 increases reactive oxygen species following hypoxia and high-salt diet in the mouse glomerulus.

J B Heimlich1, J S Speed, C J Bloom, P M O'Connor, J S Pollock, D M Pollock.   

Abstract

AIM: This study was designed to determine whether ET-1 derived from endothelial cells contributes to oxidative stress in the glomerulus of mice subjected to a high-salt diet and/or hypoxia.
METHODS: C57BL6/J control mice or vascular endothelial cell ET-1 knockout (VEET KO) mice were subjected to 3-h exposure to hypoxia (8% O₂) and/or 2 weeks of high-salt diet (4% NaCl) prior to metabolic cage assessment of renal function and isolation of glomeruli for the determination of reactive oxygen species (ROS).
RESULTS: In control mice, hypoxia significantly increased urinary protein excretion during the initial 24 h, but only in animals on a high-salt diet. Hypoxia increased glomerular ET-1 mRNA expression in control, but not in vascular endothelial cell ET-1 knockout (VEET KO) mice. Under normoxic conditions, mice on a high-salt diet had approx. 150% higher glomerular ET-1 mRNA expression compared with a normal-salt diet (P < 0.05). High-salt diet administration significantly increased glomerular ROS production in flox control, but not in glomeruli isolated from VEET KO mice. In C57BL6/J mice, the ETA receptor-selective antagonist, ABT-627, significantly attenuated the increase in glomerular ROS production produced by high-salt diet. In addition, chronic infusion of C57BL6/J mice with a subpressor dose of ET-1 (osmotic pumps) significantly increased the levels of glomerular ROS that were prevented by ETA antagonist treatment.
CONCLUSION: These data suggest that both hypoxia and a high-salt diet increase glomerular ROS production via endothelial-derived ET-1-ETA receptor activation and provide a potential mechanism for ET-1-induced nephropathy.
© 2014 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  endothelin; glomerulus; high-salt diet; hypoxia; kidney; reactive oxygen species

Mesh:

Substances:

Year:  2014        PMID: 25219340      PMCID: PMC4308436          DOI: 10.1111/apha.12397

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  24 in total

1.  Acute hypoxia and endogenous renal endothelin.

Authors:  A Nir; A L Clavell; D Heublein; L L Aarhus; J C Burnett
Journal:  J Am Soc Nephrol       Date:  1994-05       Impact factor: 10.121

2.  NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1.

Authors:  Ahmed A Elmarakby; E Dabbs Loomis; Jennifer S Pollock; David M Pollock
Journal:  Hypertension       Date:  2004-12-27       Impact factor: 10.190

3.  Endothelin up-regulation and localization following renal ischemia and reperfusion.

Authors:  S M Wilhelm; M S Simonson; A V Robinson; N T Stowe; J A Schulak
Journal:  Kidney Int       Date:  1999-03       Impact factor: 10.612

4.  Collecting duct-specific knockout of endothelin-1 causes hypertension and sodium retention.

Authors:  Dowhan Ahn; Yuqiang Ge; Peter K Stricklett; Pritmohinder Gill; Deborah Taylor; Alisa K Hughes; Masashi Yanagisawa; Lance Miller; Raoul D Nelson; Donald E Kohan
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

5.  Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase.

Authors:  Chagriya Kitiyakara; Tina Chabrashvili; Yifan Chen; Jonathan Blau; Alex Karber; Shakil Aslam; William J Welch; Christopher S Wilcox
Journal:  J Am Soc Nephrol       Date:  2003-11       Impact factor: 10.121

6.  Hypoxia induces endothelin gene expression and secretion in cultured human endothelium.

Authors:  S Kourembanas; P A Marsden; L P McQuillan; D V Faller
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

7.  Osmolar regulation of endothelin-1 production by rat inner medullary collecting duct.

Authors:  D E Kohan; E Padilla
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

8.  Characterization of a novel, high-molecular weight, acidic, endothelin-1 inactivating metalloendopeptidase from the rat kidney.

Authors:  J Janas; D Sitkiewicz; K Warnawin; R M Janas
Journal:  J Hypertens       Date:  1994-10       Impact factor: 4.844

9.  Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia.

Authors:  H Li; S J Chen; Y F Chen; Q C Meng; J Durand; S Oparil; T S Elton
Journal:  J Appl Physiol (1985)       Date:  1994-09

10.  Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome.

Authors:  M Kestilä; U Lenkkeri; M Männikkö; J Lamerdin; P McCready; H Putaala; V Ruotsalainen; T Morita; M Nissinen; R Herva; C E Kashtan; L Peltonen; C Holmberg; A Olsen; K Tryggvason
Journal:  Mol Cell       Date:  1998-03       Impact factor: 17.970

View more
  12 in total

1.  Endothelin type A receptor inhibition normalises intrarenal hypoxia in rats used as a model of type 1 diabetes by improving oxygen delivery.

Authors:  Stephanie Franzén; Fredrik Palm
Journal:  Diabetologia       Date:  2015-07-15       Impact factor: 10.122

Review 2.  Endothelium-derived ET-1 and the development of renal injury.

Authors:  Carmen De Miguel; David M Pollock; Jennifer S Pollock
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-05-20       Impact factor: 3.619

3.  Long-Term Endothelin-A Receptor Antagonism Provides Robust Renal Protection in Humanized Sickle Cell Disease Mice.

Authors:  Malgorzata Kasztan; Brandon M Fox; Joshua S Speed; Carmen De Miguel; Eman Y Gohar; Tim M Townes; Abdullah Kutlar; Jennifer S Pollock; David M Pollock
Journal:  J Am Soc Nephrol       Date:  2017-03-27       Impact factor: 10.121

4.  Elevated plasma endothelin-1 is associated with reduced weight loss post vertical sleeve gastrectomy.

Authors:  Haley N Jenkins; London J Williams; Adam Dungey; Kenneth D Vick; Bernadette E Grayson; Joshua S Speed
Journal:  Surg Obes Relat Dis       Date:  2019-04-09       Impact factor: 4.734

5.  Endothelin receptor blockade blunts the pressor response to acute stress in men and women with obesity.

Authors:  Cassandra C Derella; Anson M Blanks; Xiaoling Wang; Matthew A Tucker; Chase Horsager; Jin Hee Jeong; Paula Rodriguez-Miguelez; Jacob Looney; Jeffrey Thomas; David M Pollock; Ryan A Harris
Journal:  J Appl Physiol (1985)       Date:  2021-11-11

Review 6.  Regulation, signalling and functions of hormonal peptides in pulmonary vascular remodelling during hypoxia.

Authors:  Priya Gaur; Supriya Saini; Praveen Vats; Bhuvnesh Kumar
Journal:  Endocrine       Date:  2018-01-30       Impact factor: 3.633

7.  Endothelin-1 contributes to the progression of renal injury in sickle cell disease via reactive oxygen species.

Authors:  J Brett Heimlich; Joshua S Speed; Paul M O'Connor; Jennifer S Pollock; Tim M Townes; Steffen E Meiler; Abdullah Kutlar; David M Pollock
Journal:  Br J Pharmacol       Date:  2016-01       Impact factor: 8.739

8.  High salt induces autocrine actions of ET-1 on inner medullary collecting duct NO production via upregulated ETB receptor expression.

Authors:  Kelly Anne Hyndman; Courtney Dugas; Alexandra M Arguello; Traci T Goodchild; Kathleen M Buckley; Mariah Burch; Masashi Yanagisawa; Jennifer S Pollock
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-06-08       Impact factor: 3.619

Review 9.  Endothelin receptor antagonists in sickle cell disease: A promising new therapeutic approach.

Authors:  Brandon M Fox; Malgorzata Kasztan
Journal:  Life Sci       Date:  2016-04-03       Impact factor: 5.037

Review 10.  Endothelin.

Authors:  Anthony P Davenport; Kelly A Hyndman; Neeraj Dhaun; Christopher Southan; Donald E Kohan; Jennifer S Pollock; David M Pollock; David J Webb; Janet J Maguire
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.